
Sign up to save your podcasts
Or


In this episode, YS Chi talks to Rhett Alden who joined Elsevier with “the idea, the expectation, that we’re really going to do something significant in the healthcare space to improve patients’ lives”.
YS asks Rhett how it was possible to make such quick progress with the Covid vaccines, how to continue the push for more open access to information and how to build trust. Rhett shares his insights on all the possibilities that come with bringing different large data sets together to better understand patients, the exciting developments in oncology and the latest tools that are helping doctors find the best cancer treatments.
Rhett Alden is the chief technology officer for health and commercial markets at Elsevier.
This podcast is brought to you by RELX.
By RELX4.6
1111 ratings
In this episode, YS Chi talks to Rhett Alden who joined Elsevier with “the idea, the expectation, that we’re really going to do something significant in the healthcare space to improve patients’ lives”.
YS asks Rhett how it was possible to make such quick progress with the Covid vaccines, how to continue the push for more open access to information and how to build trust. Rhett shares his insights on all the possibilities that come with bringing different large data sets together to better understand patients, the exciting developments in oncology and the latest tools that are helping doctors find the best cancer treatments.
Rhett Alden is the chief technology officer for health and commercial markets at Elsevier.
This podcast is brought to you by RELX.

2,203 Listeners

1,095 Listeners

2,356 Listeners

4,809 Listeners

177 Listeners

798 Listeners

211 Listeners

1,375 Listeners

37 Listeners

417 Listeners

545 Listeners

349 Listeners

2,707 Listeners

3,317 Listeners

187 Listeners